New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
SAMETA Trial Evaluates Efficacy of Savolitinib Plus Durvalumab in MET-Driven Papillary RCC

SAMETA Trial Evaluates Efficacy of Savolitinib Plus Durvalumab in MET-Driven Papillary RCC

The safety and efficacy achieved with the combination of savolitinib and durvalumab (Imfinzi) vs standard-of-care sunitinib (Sutent) or durvalumab monotherapy will be evaluated in patients withM
World medicine November 07,2023
SAMETA Trial Evaluates Efficacy of Savolitinib Plus Durvalumab in MET-Driven Papillary RCC

SAMETA Trial Evaluates Efficacy of Savolitinib Plus Durvalumab in MET-Driven Papillary RCC

The safety and efficacy achieved with the combination of savolitinib and durvalumab (Imfinzi) vs standard-of-care sunitinib (Sutent) or durvalumab monotherapy will be evaluated in patients withM
World medicine November 07,2023
Healthy eating may be a key player in COPD risk reduction

Healthy eating may be a key player in COPD risk reduction

In a recent study published inBMC Public Health,researchers investigated the association between diet quality measured by the Healthy Eating Index-2010 (HEI-2010) score and the odds of Chr
World medicine November 07,2023
Healthy eating may be a key player in COPD risk reduction

Healthy eating may be a key player in COPD risk reduction

In a recent study published inBMC Public Health,researchers investigated the association between diet quality measured by the Healthy Eating Index-2010 (HEI-2010) score and the odds of Chr
World medicine November 07,2023
PROSPECT Trial Looks to Add Effective Option for Patients With R/R PCNSL

PROSPECT Trial Looks to Add Effective Option for Patients With R/R PCNSL

Efforts to develop the first FDA-approved agent specifically for patients with primary central nervous system lymphoma (PCNSL) have been initiated with the phase 2 PROSPECT trial (NCT04947319).1“PCNSL
World medicine November 07,2023
PROSPECT Trial Looks to Add Effective Option for Patients With R/R PCNSL

PROSPECT Trial Looks to Add Effective Option for Patients With R/R PCNSL

Efforts to develop the first FDA-approved agent specifically for patients with primary central nervous system lymphoma (PCNSL) have been initiated with the phase 2 PROSPECT trial (NCT04947319).1“PCNSL
World medicine November 07,2023
Influence of healthy lifestyle habits on chronic disorders

Influence of healthy lifestyle habits on chronic disorders

In a recent editorial published inNutrients, researchers described the health benefits of regular exercise, a healthy diet, and adequate sleep.Study:Effects of Healthy Lifestyles on Chroni
World medicine November 07,2023
Influence of healthy lifestyle habits on chronic disorders

Influence of healthy lifestyle habits on chronic disorders

In a recent editorial published inNutrients, researchers described the health benefits of regular exercise, a healthy diet, and adequate sleep.Study:Effects of Healthy Lifestyles on Chroni
World medicine November 07,2023
Is health a human right? The American College of Physicians answers with an emphatic YES!

Is health a human right? The American College of Physicians answers with an emphatic YES!

In a recent position paper published in theAnnuals of Internal Medicine, representatives of the American College of Physicians (ACP's) Ethics, Professionalism, and Human Rights Committee hig
World medicine November 07,2023
Is health a human right? The American College of Physicians answers with an emphatic YES!

Is health a human right? The American College of Physicians answers with an emphatic YES!

In a recent position paper published in theAnnuals of Internal Medicine, representatives of the American College of Physicians (ACP's) Ethics, Professionalism, and Human Rights Committee hig
World medicine November 07,2023
PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

According to a comparative analysis conducted based on propensity score matching, anti–PD-1 therapy with either pembrolizumab (Keytruda) or nivolumab (Opdivo) significantly improved overall survival (
World medicine November 07,2023
PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

According to a comparative analysis conducted based on propensity score matching, anti–PD-1 therapy with either pembrolizumab (Keytruda) or nivolumab (Opdivo) significantly improved overall survival (
World medicine November 07,2023
New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.The INTER
World medicine November 07,2023
New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.The INTER
World medicine November 07,2023
UTHealth Houston study to examine how eviction protection during the pandemic affects mental health

UTHealth Houston study to examine how eviction protection during the pandemic affects mental health

During the COVID-19 pandemic, eviction moratoria prevented or delayed many people from experiencing homelessness. But now that the pandemic is over and the short-term eviction protection has ended, th
World medicine November 07,2023
UTHealth Houston study to examine how eviction protection during the pandemic affects mental health

UTHealth Houston study to examine how eviction protection during the pandemic affects mental health

During the COVID-19 pandemic, eviction moratoria prevented or delayed many people from experiencing homelessness. But now that the pandemic is over and the short-term eviction protection has ended, th
World medicine November 07,2023
mRNA-4157 Plus Pembrolizumab Under Further Investigation in Phase 3 Trial in High-Risk Melanoma

mRNA-4157 Plus Pembrolizumab Under Further Investigation in Phase 3 Trial in High-Risk Melanoma

The combination of mRNA-4157 (V940) and pembrolizumab (Keytruda) will be further evaluated as an adjuvant treatment option for patients with resected, high-risk, stage IIB to IV melanoma in the phase
World medicine November 07,2023
mRNA-4157 Plus Pembrolizumab Under Further Investigation in Phase 3 Trial in High-Risk Melanoma

mRNA-4157 Plus Pembrolizumab Under Further Investigation in Phase 3 Trial in High-Risk Melanoma

The combination of mRNA-4157 (V940) and pembrolizumab (Keytruda) will be further evaluated as an adjuvant treatment option for patients with resected, high-risk, stage IIB to IV melanoma in the phase
World medicine November 07,2023
Butterfly-inspired imaging sensor can detect cancer cells with high accuracy

Butterfly-inspired imaging sensor can detect cancer cells with high accuracy

There are many creatures on our planet with more advanced senses than humans. Turtles can sense Earth's magnetic field. Mantis shrimp can detect polarized light. Elephants can hear much lower freq
World medicine November 07,2023
Butterfly-inspired imaging sensor can detect cancer cells with high accuracy

Butterfly-inspired imaging sensor can detect cancer cells with high accuracy

There are many creatures on our planet with more advanced senses than humans. Turtles can sense Earth's magnetic field. Mantis shrimp can detect polarized light. Elephants can hear much lower freq
World medicine November 07,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com